Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Clinical trial NCT00027690 · COMPLETED

Trial details

NCT number: NCT00027690
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Corpus Carcinoma

Start date: 2002-06-01
Primary completion: 2004-09-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.